Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$0.53 - $0.93 $377 - $663
713 Added 1.45%
49,723 $28,000
Q4 2023

Feb 05, 2024

BUY
$0.63 - $1.14 $5,125 - $9,273
8,135 Added 19.9%
49,010 $40,000
Q3 2023

Nov 06, 2023

BUY
$1.12 - $1.88 $7,275 - $12,212
6,496 Added 18.9%
40,875 $46,000
Q2 2023

Jul 27, 2023

BUY
$1.31 - $2.04 $4,769 - $7,427
3,641 Added 11.85%
34,379 $55,000
Q1 2023

May 02, 2023

BUY
$1.45 - $2.95 $2,631 - $5,354
1,815 Added 6.28%
30,738 $46,000
Q4 2022

Feb 09, 2023

SELL
$2.02 - $3.25 $26 - $42
-13 Reduced 0.04%
28,923 $69,000
Q3 2022

Nov 02, 2022

SELL
$1.96 - $3.14 $14,168 - $22,699
-7,229 Reduced 19.99%
28,936 $59,000
Q2 2022

Aug 01, 2022

BUY
$1.3 - $2.64 $2,614 - $5,309
2,011 Added 5.89%
36,165 $70,000
Q1 2022

May 04, 2022

BUY
$2.35 - $3.47 $2,122 - $3,133
903 Added 2.72%
34,154 $63,000
Q4 2021

Feb 07, 2022

BUY
$2.92 - $5.74 $7,244 - $14,240
2,481 Added 8.06%
33,251 $107,000
Q3 2021

Nov 02, 2021

BUY
$4.98 - $6.63 $8,351 - $11,118
1,677 Added 5.76%
30,770 $162,000
Q2 2021

Aug 03, 2021

BUY
$2.56 - $5.49 $6,464 - $13,862
2,525 Added 9.5%
29,093 $160,000
Q1 2021

May 04, 2021

SELL
$2.69 - $5.25 $1,366 - $2,667
-508 Reduced 1.88%
26,568 $72,000
Q4 2020

Feb 01, 2021

BUY
$3.17 - $4.49 $12,800 - $18,130
4,038 Added 17.53%
27,076 $86,000
Q3 2020

Nov 09, 2020

SELL
$2.98 - $5.2 $1,951 - $3,406
-655 Reduced 2.76%
23,038 $92,000
Q2 2020

Aug 07, 2020

BUY
$2.29 - $4.24 $5,175 - $9,582
2,260 Added 10.54%
23,693 $93,000
Q1 2020

May 04, 2020

SELL
$1.92 - $4.39 $4,206 - $9,618
-2,191 Reduced 9.27%
21,433 $53,000
Q4 2019

Feb 06, 2020

BUY
$2.41 - $4.4 $14,112 - $25,766
5,856 Added 32.96%
23,624 $96,000
Q4 2019

Feb 04, 2020

SELL
$2.41 - $4.4 $2,622 - $4,787
-1,088 Reduced 5.77%
17,768 $66,000
Q3 2019

Nov 12, 2019

BUY
$2.17 - $3.14 $40,917 - $59,207
18,856 New
18,856 $49,000
Q3 2018

Nov 01, 2018

SELL
$1.59 - $2.42 $5,870 - $8,934
-3,692 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
3,692
3,692 $14,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.